HIV-1 gp120 T cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemprophylaxis Trial.

Authors

Peter J. Kuebler
Brian I. Shaw
Kaitlyn S. Leadabrand
Megha L. Mehrotra
Robert M. Grant
Esper G. Kallás
Douglas F. NixonFollow

Document Type

Journal Article

Publication Date

12-15-2015

Journal

Journal of Acquired Immune Deficiency Syndromes

DOI

10.1097/QAI.0000000000000923

Comments

[epub ahead of print]

APA Citation

Kuebler, P. J., Shaw, B. I., Leadabrand, K. S., Mehrotra, M. L., Grant, R. M., Kallás, E. G., & Nixon, D. F. (2015). HIV-1 gp120 T cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemprophylaxis Trial.. Journal of Acquired Immune Deficiency Syndromes, (). http://dx.doi.org/10.1097/QAI.0000000000000923